|

albuterol nebulizer Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • National Heart, Lung, and Blood Institute (NHLBI)1

Indications

  • Lymphangioleiomyomatosis1
  • Cancer1

Bethesda, Maryland1 trial

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

National Institutes of Health Clinical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.